Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IPL | Ann: Notification of cessation of securities - IPL | 19/09/24 | 0 | 1 | |||
|
|||||||
IPL | Ann: Update - Notification of buy-back - IPL | 19/09/24 | 0 | 1 | |||
|
|||||||
IPL | Ann: FY19 Third Quarter Dividend | 20/02/19 | 0 | 103 | |||
|
|||||||
IPL | Ann: Share Buyback Programme Paused | 11/02/19 | 0 | 97 | |||
|
|||||||
IPL | Ann: Investore Share Buyback | 11/02/19 | 0 | 101 | |||
|
|||||||
IPL | Ann: Investore Share Buyback | 07/02/19 | 0 | 99 | |||
|
|||||||
IPL | Ann: Investore Share Buyback | 05/02/19 | 0 | 103 | |||
|
|||||||
IPL | Ann: Investore Share Buyback | 04/02/19 | 0 | 107 | |||
|
See All Discussions